G. Krzymanski et al., THE USE OF BONE-MARROW-DERIVED FIBROBLASTOID CELLS AND FRESH BONE-MARROW IN THE TREATMENT OF BONE DEFECTS - AN EXPERIMENTAL-STUDY, International journal of oral and maxillofacial surgery, 26(1), 1997, pp. 55-60
Bone-marrow aspirate (containing bone progenitor cells), in vitro expa
nded autologous bone-marrow-derived stromal fibroblastoid cells, and a
combination thereof were tested for the potential to fill bone defect
s. They were compared to grafts of fresh autologous bone or allogeneic
devitalized bone. Mandibular defects in rabbits were chosen for this
study. The best results were obtained with a combination of in vitro e
xpanded bone-marrow-derived stromal fibroblastoid cells and fresh auto
logous bone marrow or fresh autologous marrow alone. The effects of th
ese two grafts were similar to grafts of fresh autologous bone and sig
nificantly superior to grafts of devitalized allogeneic bone providing
only a bone matrix. The in vitro ex panded marrow stromal cells induc
ed very significant bone ingrowth, and their effects were only slightl
y inferior to fresh autologous bone but were superior to devitalized a
llogeneic bone. These studies suggest that bone marrow is a good sourc
e of osteogenic cells both for immediate transplantation and for in vi
tro expansion and subsequent transplantation.